BE724364A - - Google Patents
Info
- Publication number
- BE724364A BE724364A BE724364A BE724364A BE724364A BE 724364 A BE724364 A BE 724364A BE 724364 A BE724364 A BE 724364A BE 724364 A BE724364 A BE 724364A BE 724364 A BE724364 A BE 724364A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT1064767A AT280290B (de) | 1967-11-24 | 1967-11-24 | Verfahren zur Herstellung von neuen 1-Phenyl-4-alkyl-3H-1,4-benzodiazepin-2,5-[1H,4H]-dionen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE724364A true BE724364A (enExample) | 1969-05-22 |
Family
ID=3623762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE724364A BE724364A (enExample) | 1967-11-24 | 1968-11-22 |
Country Status (13)
| Country | Link |
|---|---|
| AT (1) | AT280290B (enExample) |
| BE (1) | BE724364A (enExample) |
| BR (1) | BR6804236D0 (enExample) |
| CH (1) | CH523265A (enExample) |
| DE (1) | DE1810423B2 (enExample) |
| DK (1) | DK124950B (enExample) |
| ES (2) | ES360410A1 (enExample) |
| FR (2) | FR1593335A (enExample) |
| GB (1) | GB1173540A (enExample) |
| IE (1) | IE32504B1 (enExample) |
| IL (1) | IL31146A (enExample) |
| NL (1) | NL6815755A (enExample) |
| SE (1) | SE356979B (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3914216A (en) * | 1962-12-18 | 1975-10-21 | Boehringer Sohn Ingelheim | 1-Phenyl-3H-1,4-benzodiazepine-2,5-(1H,4H)-diones |
| DE2117438A1 (de) * | 1971-04-08 | 1972-10-19 | CH. Boehringer Sohn, 6507 Ingelheim | Neue substituiert 1,3-Dihydro-2H-1 ^-benzodiazepine^-one |
| BE793460A (fr) * | 1971-12-29 | 1973-06-28 | Boehringer Sohn Ingelheim | Nouvelles 1-aryl-3h,1,4-benzodiazepine-2,5-(1h |
| JP5127096B2 (ja) * | 1999-04-30 | 2013-01-23 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | アポトーシスにより誘導される自己免疫疾患を処置するためのベンゾジアゼピンの使用 |
| US7144880B2 (en) | 1999-04-30 | 2006-12-05 | Regents Of The University Of Michigan | Compositions relating to novel compounds and targets thereof |
| US7276348B2 (en) | 1999-04-30 | 2007-10-02 | Regents Of The University Of Michigan | Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof |
| US20060025388A1 (en) | 1999-04-30 | 2006-02-02 | Glick Gary D | Compositions and methods relating to novel compounds and targets thereof |
| US7691582B2 (en) | 2002-09-27 | 2010-04-06 | The Regents Of The University Of Michigan | Methods of secretory vimentin detection and modulation |
| JP2008528448A (ja) | 2005-01-03 | 2008-07-31 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 新規化合物に関連する組成物および方法、ならびにその標的 |
| JP2008545757A (ja) | 2005-06-01 | 2008-12-18 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 溶媒和されていないベンゾジアゼピン組成物および方法 |
| EP1948191B1 (en) | 2005-11-01 | 2013-01-16 | The Regents of the University of Michigan | Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties |
| US7759338B2 (en) | 2006-04-27 | 2010-07-20 | The Regents Of The University Of Michigan | Soluble 1,4 benzodiazepine compounds and stable salts thereof |
| EP2418206A3 (en) | 2006-06-09 | 2012-06-27 | The Regents of the University of Michigan | Benzodiazepine derivatives useful in the treatment of autoimmune disorders |
| KR101164718B1 (ko) | 2007-03-09 | 2012-07-11 | 더 리젠츠 오브 더 유니버시티 오브 미시간 | 신규 화합물 및 이의 표적에 관한 조성물 및 방법 |
| JP2010526825A (ja) * | 2007-05-10 | 2010-08-05 | エーエムアール テクノロジー インコーポレイテッド | アリール置換およびヘテロアリール置換テトラヒドロベンゾ−１，４−ジアゼピンならびにノルエピネフリン、ドーパミンおよびセロトニンの再取り込みを遮断するためのその使用 |
| MX2010002732A (es) | 2007-09-14 | 2010-06-02 | Univ Michigan | Inhibidores de f1f0-atpasa y metodos relacionados. |
| CN101918375A (zh) | 2007-11-06 | 2010-12-15 | 密歇根大学董事会 | 在皮肤病症的治疗中有用的苯并二氮杂*酮化合物 |
| US8497307B2 (en) | 2008-09-11 | 2013-07-30 | The Regents Of The University Of Michigan | Aryl guanidine F1F0-ATPase inhibitors and related methods |
| WO2010121164A2 (en) | 2009-04-17 | 2010-10-21 | The Regents Of The University Of Michigan | 1,4-benzodiazepinone compounds and their use in treating cancer |
| EP2470020A4 (en) | 2009-09-18 | 2013-03-13 | Univ Michigan | BENZODIAZEPINONE COMPOUNDS AND TREATMENT METHODS THEREWITH |
| JP5856064B2 (ja) | 2009-11-17 | 2016-02-09 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 治療特性を有する１，４−ベンゾジアゼピン−２，５−ジオンおよび関連化合物 |
| WO2011062765A2 (en) | 2009-11-17 | 2011-05-26 | The Regents Of The University Of Michigan | 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
| CA2923835C (en) * | 2013-09-11 | 2022-11-29 | The Administrators Of The Tulane Educational Fund | Novel anthranilic amides and the use thereof |
-
1967
- 1967-11-24 AT AT1064767A patent/AT280290B/de not_active IP Right Cessation
-
1968
- 1968-11-05 NL NL6815755A patent/NL6815755A/xx unknown
- 1968-11-06 SE SE15032/68A patent/SE356979B/xx unknown
- 1968-11-19 ES ES360410A patent/ES360410A1/es not_active Expired
- 1968-11-20 DK DK566968AA patent/DK124950B/da unknown
- 1968-11-22 CH CH1742668A patent/CH523265A/de not_active IP Right Cessation
- 1968-11-22 BR BR204236/68A patent/BR6804236D0/pt unknown
- 1968-11-22 DE DE19681810423 patent/DE1810423B2/de active Granted
- 1968-11-22 IE IE1425/68A patent/IE32504B1/xx unknown
- 1968-11-22 BE BE724364A patent/BE724364A/fr unknown
- 1968-11-22 FR FR1593335D patent/FR1593335A/fr not_active Expired
- 1968-11-24 IL IL31146A patent/IL31146A/en unknown
- 1968-11-25 GB GB55844/68A patent/GB1173540A/en not_active Expired
-
1969
- 1969-02-21 FR FR183259A patent/FR8310M/fr not_active Expired
-
1970
- 1970-04-23 ES ES378977A patent/ES378977A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL6815755A (enExample) | 1969-05-28 |
| AT280290B (de) | 1970-04-10 |
| GB1173540A (en) | 1969-12-10 |
| IE32504L (en) | 1969-05-24 |
| CH523265A (de) | 1972-05-31 |
| DE1810423C3 (enExample) | 1973-10-11 |
| IE32504B1 (en) | 1973-08-22 |
| DE1810423A1 (de) | 1969-10-09 |
| DK124950B (da) | 1972-12-11 |
| ES378977A1 (es) | 1973-01-16 |
| IL31146A (en) | 1972-04-27 |
| FR1593335A (enExample) | 1970-05-25 |
| ES360410A1 (es) | 1970-11-01 |
| FR8310M (enExample) | 1970-11-23 |
| BR6804236D0 (pt) | 1973-02-08 |
| IL31146A0 (en) | 1969-01-29 |
| DE1810423B2 (de) | 1973-03-22 |
| SE356979B (enExample) | 1973-06-12 |